– Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma multiforme (GBM) –
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- Culture Days 2024 Breaks Attendance Records with Over 5 Million Participants - December 4, 2024
- On the Eve of National Wreaths Across America Day, FASTPORT and Tenstreet Support the Annual Wreaths Across America Appreciation Dinner - December 4, 2024
- LBMC Expands Geographic Footprint into Memphis as Frazee Ivy Davis Joins Firm - December 4, 2024
